# ClearPoint Neuro, Inc.: filings

CLPT · Nasdaq · CIK 1285550 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clpt.md) · [Financials](/companies/clpt/financials.md) · [Filings](/companies/clpt/filings.md) · [Insiders](/companies/clpt/insiders.md)

## Reports and events: 321 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 650, 8-K 204, 424B3 74, 10-Q 45, 3 32, EFFECT 22, S-1/A 20, CORRESP 17, DEF 14A 15, 10-K 14, 144 14, D 14, UPLOAD 14, SC 13G/A 13, POS AM 11, S-8 11, SCHEDULE 13G/A 10, S-1 9, SC 13G 9, CT ORDER 7, 424B5 5, SC 13D 5, 10-12G/A 4, 10-Q/A 4, 8-A12B 4, ARS 4, DEFA14A 4, PRE 14A 4, RW 4, S-3 4, 4/A 3, CERTNAS 3, 10-K/A 2, 5 2, CERT 2, D/A 2, SC 13D/A 2, SCHEDULE 13G 2, 10-12G 1, 144/A 1, 25 1, 424B2 1, 8-K/A 1, AW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:25 ET | [10-Q](/filings/0001193125-26-436412.md) | Quarterly report, period 2026-09-30 | 0001193125-26-436412 |
| 2026-10-28 | 16:05 ET | [8-K](/filings/0001193125-26-436125.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-436125 |
| 2026-08-03 | 17:17 ET | [10-Q](/filings/0001193125-26-330842.md) | Quarterly report, period 2026-06-30 | 0001193125-26-330842 |
| 2026-08-03 | 16:05 ET | [8-K](/filings/0001193125-26-330541.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-330541 |
| 2026-05-21 | 16:30 ET | [8-K](/filings/0001193125-26-234571.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-234571 |
| 2026-05-13 | 17:00 ET | [10-Q](/filings/0001193125-26-221890.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221890 |
| 2026-05-13 | 16:05 ET | [8-K](/filings/0001193125-26-221596.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-221596 |
| 2026-04-10 | 16:30 ET | [DEF 14A](/filings/0001193125-26-151345.md) | Proxy statement, period 2026-04-10 | 0001193125-26-151345 |
| 2026-03-17 | 17:21 ET | [10-K](/filings/0001193125-26-111231.md) | Annual report, period 2025-12-31 | 0001193125-26-111231 |
| 2026-03-17 | 16:08 ET | [8-K](/filings/0001193125-26-110780.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-110780 |
| 2026-02-05 | 16:25 ET | [8-K/A](/filings/0001193125-26-039470.md) | 9.01 Financial statements and exhibits | 0001193125-26-039470 |
| 2026-01-12 | 08:31 ET | [8-K](/filings/0001193125-26-009867.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009867 |
| 2026-01-05 | 08:30 ET | [8-K](/filings/0001193125-26-001581.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-001581 |
| 2025-11-20 | 17:08 ET | [8-K](/filings/0001193125-25-290003.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-290003 |
| 2025-11-06 | 17:20 ET | [10-Q](/filings/0001193125-25-270123.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270123 |
| 2025-11-06 | 16:57 ET | [8-K](/filings/0001193125-25-270019.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-270019 |
| 2025-11-06 | 16:52 ET | [8-K](/filings/0001193125-25-269992.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-269992 |
| 2025-08-12 | 17:19 ET | [10-Q](/filings/0001285550-25-000012.md) | Quarterly report, period 2025-06-30 | 0001285550-25-000012 |
| 2025-08-12 | 16:05 ET | [8-K](/filings/0001285550-25-000010.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-25-000010 |
| 2025-06-17 | 16:15 ET | [8-K](/filings/0001683168-25-004550.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-004550 |
| 2025-05-23 | 16:30 ET | [8-K](/filings/0000950170-25-076992.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-076992 |
| 2025-05-19 | 16:30 ET | [8-K](/filings/0000950170-25-074397.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-074397 |
| 2025-05-13 | 17:24 ET | [10-Q](/filings/0000950170-25-070545.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070545 |
| 2025-05-13 | 16:10 ET | [8-K](/filings/0000950170-25-070346.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-070346 |
| 2025-05-12 | 16:06 ET | [8-K](/filings/0000950170-25-069175.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-069175 |
| 2025-04-09 | 16:22 ET | [DEF 14A](/filings/0000950170-25-052528.md) | Proxy statement, period 2025-05-21 | 0000950170-25-052528 |
| 2025-02-26 | 17:17 ET | [10-K](/filings/0000950170-25-027934.md) | Annual report, period 2024-12-31 | 0000950170-25-027934 |
| 2025-02-26 | 16:05 ET | [8-K](/filings/0000950170-25-027716.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-027716 |
| 2024-11-07 | 17:02 ET | [8-K](/filings/0001104659-24-115372.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-115372 |
| 2024-11-07 | 16:12 ET | [10-Q](/filings/0001285550-24-000121.md) | Quarterly report, period 2024-09-30 | 0001285550-24-000121 |
| 2024-11-07 | 16:07 ET | [8-K](/filings/0001285550-24-000120.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000120 |
| 2024-08-26 | 16:06 ET | [8-K](/filings/0001285550-24-000107.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000107 |
| 2024-08-07 | 17:16 ET | [10-Q](/filings/0001285550-24-000098.md) | Quarterly report, period 2024-06-30 | 0001285550-24-000098 |
| 2024-08-07 | 16:05 ET | [8-K](/filings/0001285550-24-000097.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000097 |
| 2024-05-16 | 06:04 ET | [8-K](/filings/0001285550-24-000061.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001285550-24-000061 |
| 2024-05-07 | 17:17 ET | [10-Q](/filings/0001285550-24-000051.md) | Quarterly report, period 2024-03-31 | 0001285550-24-000051 |
| 2024-05-07 | 16:05 ET | [8-K](/filings/0001285550-24-000049.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000049 |
| 2024-04-05 | 16:34 ET | [DEF 14A](/filings/0001285550-24-000045.md) | Proxy statement, period 2023-12-31 | 0001285550-24-000045 |
| 2024-03-12 | 17:17 ET | [10-K](/filings/0001285550-24-000031.md) | Annual report, period 2023-12-31 | 0001285550-24-000031 |
| 2024-03-12 | 16:05 ET | [8-K](/filings/0001285550-24-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000030 |
| 2024-03-01 | 16:05 ET | [8-K](/filings/0001104659-24-029960.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-029960 |
| 2024-01-08 | 16:07 ET | [8-K](/filings/0001285550-24-000016.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-24-000016 |
| 2023-11-09 | 17:09 ET | [10-Q](/filings/0001285550-23-000115.md) | Quarterly report, period 2023-09-30 | 0001285550-23-000115 |
| 2023-11-09 | 16:05 ET | [8-K](/filings/0001285550-23-000114.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-23-000114 |
| 2023-08-08 | 17:25 ET | [10-Q](/filings/0001285550-23-000097.md) | Quarterly report, period 2023-06-30 | 0001285550-23-000097 |
| 2023-08-08 | 16:06 ET | [8-K](/filings/0001285550-23-000096.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001285550-23-000096 |
| 2023-08-01 | 16:48 ET | [8-K](/filings/0001285550-23-000091.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001285550-23-000091 |
| 2023-05-25 | 16:23 ET | [8-K](/filings/0001285550-23-000050.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001285550-23-000050 |
| 2023-05-22 | 17:04 ET | [8-K](/filings/0001285550-23-000048.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001285550-23-000048 |
| 2023-05-11 | 17:17 ET | [10-Q](/filings/0001285550-23-000046.md) | Quarterly report, period 2023-03-31 | 0001285550-23-000046 |

Page 1 of 7. [Older](/companies/clpt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 05:15 ET. No prices; not investment advice.